JP2020502183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502183A5 JP2020502183A5 JP2019532941A JP2019532941A JP2020502183A5 JP 2020502183 A5 JP2020502183 A5 JP 2020502183A5 JP 2019532941 A JP2019532941 A JP 2019532941A JP 2019532941 A JP2019532941 A JP 2019532941A JP 2020502183 A5 JP2020502183 A5 JP 2020502183A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- amino acid
- composition
- acid entity
- tripeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662436073P | 2016-12-19 | 2016-12-19 | |
| US62/436,073 | 2016-12-19 | ||
| US201762443205P | 2017-01-06 | 2017-01-06 | |
| US62/443,205 | 2017-01-06 | ||
| US201762491776P | 2017-04-28 | 2017-04-28 | |
| US62/491,776 | 2017-04-28 | ||
| US201762545358P | 2017-08-14 | 2017-08-14 | |
| US62/545,358 | 2017-08-14 | ||
| US201762576321P | 2017-10-24 | 2017-10-24 | |
| US62/576,321 | 2017-10-24 | ||
| PCT/US2017/067368 WO2018118957A1 (en) | 2016-12-19 | 2017-12-19 | Amino acid compositions and methods for the treatment of muscle diseases and disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502183A JP2020502183A (ja) | 2020-01-23 |
| JP2020502183A5 true JP2020502183A5 (enExample) | 2021-02-12 |
Family
ID=61025047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019532941A Pending JP2020502183A (ja) | 2016-12-19 | 2017-12-19 | アミノ酸組成物ならびに筋肉疾患および障害の治療方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20180207119A1 (enExample) |
| EP (1) | EP3554493A1 (enExample) |
| JP (1) | JP2020502183A (enExample) |
| KR (1) | KR20190099243A (enExample) |
| CN (1) | CN110267655A (enExample) |
| AU (1) | AU2017379825A1 (enExample) |
| BR (1) | BR112019012476A2 (enExample) |
| CA (1) | CA3046558A1 (enExample) |
| CL (1) | CL2019001685A1 (enExample) |
| CO (1) | CO2019006292A2 (enExample) |
| CU (1) | CU20190057A7 (enExample) |
| EC (1) | ECSP19043725A (enExample) |
| IL (1) | IL267210A (enExample) |
| JO (1) | JOP20190147A1 (enExample) |
| MA (1) | MA50763A (enExample) |
| MX (1) | MX2019007352A (enExample) |
| PE (1) | PE20191206A1 (enExample) |
| PH (1) | PH12019501339A1 (enExample) |
| TW (1) | TWI780096B (enExample) |
| WO (1) | WO2018118957A1 (enExample) |
| ZA (1) | ZA201903581B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| WO2018201024A1 (en) | 2017-04-28 | 2018-11-01 | Axcella Health Inc. | Amino acid compositions and their use for the treatment of traumatic brain injury |
| JP7370960B2 (ja) * | 2017-08-14 | 2023-10-30 | アクセラ・ヘルス・インコーポレイテッド | 神経細胞損傷の治療のためのアミノ酸組成物 |
| MX2020001765A (es) | 2017-08-14 | 2020-07-29 | Axcella Health Inc | Composiciones de aminoacidos para el tratamiento de enfermedad hepatica. |
| JP2021529735A (ja) | 2018-06-20 | 2021-11-04 | アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． | アミノ酸組成物の製造方法 |
| EP3810276A1 (en) * | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the reduction or treatment of inflammation |
| CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
| CN112839643A (zh) | 2018-06-20 | 2021-05-25 | 胺细拉健康公司 | 用于治疗肌肉中脂肪浸润的组合物及方法 |
| JP2022501321A (ja) * | 2018-09-27 | 2022-01-06 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | インスリン抵抗性及び／又は糖尿病の予防のための、ヒスチジンとグリシンと他のアミノ酸の使用 |
| CN113924089A (zh) * | 2019-06-07 | 2022-01-11 | 雀巢产品有限公司 | 使用一种或多种自噬诱发氨基酸来增强一种或多种合成代谢氨基酸的肌肉骨骼效应的组合物和方法 |
| US20220184015A1 (en) * | 2019-06-20 | 2022-06-16 | Societe Des Produits Nestle S.A. | Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids on bone health |
| IT201900010437A1 (it) | 2019-06-28 | 2020-12-28 | Dompe Farm Spa | Composizione per il trattamento del deperimento muscolare |
| KR102338447B1 (ko) * | 2019-09-24 | 2021-12-14 | 마이오텍사이언스 주식회사 | 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
| WO2021060880A1 (ko) * | 2019-09-24 | 2021-04-01 | 마이오텍사이언스 주식회사 | 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
| KR102456270B1 (ko) * | 2019-09-24 | 2022-10-19 | 마이오텍사이언스 주식회사 | 비천연 아미노산 유도체를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
| CN110801007A (zh) * | 2019-12-17 | 2020-02-18 | 苟春虎 | 老年肌少症营养肽 |
| WO2021178860A1 (en) * | 2020-03-06 | 2021-09-10 | Axcella Health Inc. | Amino acid compositions and methods for muscle and myotube modulation |
| KR102802853B1 (ko) * | 2021-02-26 | 2025-05-07 | 이엑스헬스케어 주식회사 | 피부 유래 엑소좀을 통해 근손실 억제 또는 근생성 촉진 효과를 나타내는 조성물 |
| CN113288890B (zh) * | 2021-06-21 | 2022-02-22 | 南方医科大学南方医院 | N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用 |
| WO2024026307A1 (en) | 2022-07-25 | 2024-02-01 | Axcella Health Inc. | Biomarker for long covid and fatigue |
| WO2024030909A1 (en) | 2022-08-01 | 2024-02-08 | Axcella Health Inc. | Biomarkers of amino acid composition treatment response in long covid |
| WO2025167857A1 (zh) * | 2024-02-06 | 2025-08-14 | 南京纽邦生物科技有限公司 | 用于增强或改善肌肉功能和/或提高运动表现和/或预防或缓解疲劳的方法和组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20022927A3 (cs) * | 2000-02-01 | 2003-06-18 | Muscletech Research And Development Inc. | Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly |
| US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| US20060002913A1 (en) * | 2004-06-22 | 2006-01-05 | Gehlsen Kurt R | Use of histamine and related compounds to treat disorders affecting muscle function |
| WO2006105112A2 (en) * | 2005-03-29 | 2006-10-05 | Ajinomoto Co., Inc. | Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
| JP2007023921A (ja) * | 2005-07-19 | 2007-02-01 | Toyota Motor Corp | 内燃機関の制御装置 |
| US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
| CN100518815C (zh) * | 2007-02-15 | 2009-07-29 | 北京苏里曼医药科技有限公司 | 一种氨基酸组合物 |
| EP2744356A4 (en) * | 2011-08-19 | 2015-05-27 | Musclepharm Corp | COMPOSITIONS AND METHODS FOR INHIBITING INCOUNTERANCE IN ANIMALS |
| JP2017501113A (ja) * | 2013-10-23 | 2017-01-12 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | アミノ酸によるｍＴＯＲＣ１の調節およびその使用 |
-
2017
- 2017-06-16 JO JOP/2019/0147A patent/JOP20190147A1/ar unknown
- 2017-12-19 TW TW106144666A patent/TWI780096B/zh not_active IP Right Cessation
- 2017-12-19 PE PE2019001282A patent/PE20191206A1/es unknown
- 2017-12-19 JP JP2019532941A patent/JP2020502183A/ja active Pending
- 2017-12-19 EP EP17835529.3A patent/EP3554493A1/en not_active Withdrawn
- 2017-12-19 MX MX2019007352A patent/MX2019007352A/es unknown
- 2017-12-19 AU AU2017379825A patent/AU2017379825A1/en not_active Abandoned
- 2017-12-19 CU CU2019000057A patent/CU20190057A7/es unknown
- 2017-12-19 US US15/847,343 patent/US20180207119A1/en not_active Abandoned
- 2017-12-19 MA MA050763A patent/MA50763A/fr unknown
- 2017-12-19 WO PCT/US2017/067368 patent/WO2018118957A1/en not_active Ceased
- 2017-12-19 KR KR1020197020658A patent/KR20190099243A/ko not_active Ceased
- 2017-12-19 BR BR112019012476A patent/BR112019012476A2/pt not_active IP Right Cessation
- 2017-12-19 CA CA3046558A patent/CA3046558A1/en active Pending
- 2017-12-19 CN CN201780078594.XA patent/CN110267655A/zh active Pending
- 2017-12-29 US US15/858,605 patent/US20180169047A1/en not_active Abandoned
- 2017-12-29 US US15/858,475 patent/US20180169046A1/en not_active Abandoned
-
2019
- 2019-06-04 ZA ZA2019/03581A patent/ZA201903581B/en unknown
- 2019-06-10 IL IL267210A patent/IL267210A/en unknown
- 2019-06-13 PH PH12019501339A patent/PH12019501339A1/en unknown
- 2019-06-17 CO CONC2019/0006292A patent/CO2019006292A2/es unknown
- 2019-06-19 CL CL2019001685A patent/CL2019001685A1/es unknown
- 2019-06-19 EC ECSENADI201943725A patent/ECSP19043725A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502183A5 (enExample) | ||
| TWI780096B (zh) | 胺基酸組合物及肌肉疾病與病症之治療方法 | |
| JP2020530845A5 (enExample) | ||
| US7645796B2 (en) | Amino acid composition promoting collagen synthesis | |
| JP2021529736A5 (enExample) | ||
| JP2020504108A5 (enExample) | ||
| WO2005017094A3 (en) | N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency | |
| CN108721596B (zh) | 一种复方氨基酸维生素注射液及其应用 | |
| JP2013516464A5 (enExample) | ||
| RU2008126294A (ru) | Способы лечения потери мышечной массы | |
| JP2006522821A5 (enExample) | ||
| JP2021527670A5 (enExample) | ||
| JP2004537581A5 (enExample) | ||
| JPS61247354A (ja) | 栄養素組成物 | |
| JP2021527671A5 (enExample) | ||
| WO2021178860A1 (en) | Amino acid compositions and methods for muscle and myotube modulation | |
| JP2024520526A5 (enExample) | ||
| Johannessen et al. | The acute effect of valproate on cerebral energy metabolism in mice | |
| ATE541568T1 (de) | Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten | |
| JPH0116809B2 (enExample) | ||
| JP2006524182A5 (enExample) | ||
| JPWO2000043035A1 (ja) | アミノ酸含有アルブミン製剤 | |
| JP2003286168A5 (enExample) | ||
| NZ723300A (en) | Compositions for the prevention and/or treatment of pathologies associated with alpha-glucosidase | |
| RU2008123806A (ru) | Лекарственное средство, применяющееся при поражениях хряща |